1-N-[2-[4-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]piperidin-1-yl]ethyl]-3-N-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethyl]-5-[(propanoylamino)methyl]benzene-1,3-dicarboxamide

InChIKey	`QRUXDRCXIGZTGT-UHFFFAOYSA-N`
Compound Name	1-N-[2-[4-[4-(2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]piperidin-1-yl]ethyl]-3-N-[2-[4-[4-[1-[2-oxo-2-(6-oxo-5H-benzo[b][1,4]benzodiazepin-11-yl)ethyl]piperidin-4-yl]butyl]piperazin-1-yl]ethyl]-5-[(propanoylamino)methyl]benzene-1,3-dicarboxamide
Canonical SMILES	`CCC(=O)NCc1cc(C(=O)NCCN2CCC(N3CCC(n4c(=O)[nH]c5ccccc54)CC3)CC2)cc(C(=O)NCCN2CCN(CCCCC3CCN(CC(=O)N4c5ccccc5NC(=O)c5ccccc54)CC3)CC2)c1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	5
Pfam Stratification	Homologous
Avg pChEMBL	8.27
Source	ChEMBL;BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08172	CHRM2	Homo sapiens	Human	PF00001	9.4	Ki	ChEMBL;BindingDB
P11229	CHRM1	Homo sapiens	Human	PF00001	8.8	Kd	ChEMBL;BindingDB
P08173	CHRM4	Homo sapiens	Human	PF00001	8.6	Ki	ChEMBL;BindingDB
P20309	CHRM3	Homo sapiens	Human	PF00001	7.5	Ki	ChEMBL;BindingDB
P08912	CHRM5	Homo sapiens	Human	PF00001	7.0	Ki	ChEMBL;BindingDB